OnabotulinumtoxinA for Platysma Prominence: Safety and Efficacy Results from a Phase 3 Open-Label Repeat Treatment Study
Repeat onabotA treatment is well-tolerated and improves platysma prominence over the course of multiple treatment cycles.
Authors
- Ira D. Papel
- Sandhya Shimoga (ORCID: https://orcid.org/0000-0002-8039-3806)
- Steven G Yoelin
- Kenneth Beer
- R. Mccaskill
- Terrence Keaney
- Susan Weinkle
- Grace S. Park
- Warren Tong
- René Hopfinger (ORCID: https://orcid.org/0000-0003-3291-6198)
- Rodney J. Rohrich
- C. William Hanke (ORCID: https://orcid.org/0000-0002-3254-0330)
- Deanne Mraz
Institutions
- AbbVie (United States) (US)
- Dallas Plastic Surgery Institute (US)
- Palm Beach Neurology (US)
- Laser and Skin Surgery Center of Indiana (US)
- Aesthetic Surgery Center (US)
- Allergan (United States) (US)
- Medical Research Associates (US)
- Meridien Research (US)
Publication Details
- Journal
- Plastic & Reconstructive Surgery
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1097/prs.0000000000012629
- Primary Topic
- Vascular Malformations and Hemangiomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00